25 XP   0   0   10

Verona Pharma PLC ADR
Buy, Hold or Sell?

Let's analyse Verona Pharma PLC ADR together

PenkeI guess you are interested in Verona Pharma PLC ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Verona Pharma PLC ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Verona Pharma PLC ADR

I send you an email if I find something interesting about Verona Pharma PLC ADR.

Quick analysis of Verona Pharma PLC ADR (30 sec.)










What can you expect buying and holding a share of Verona Pharma PLC ADR? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
3.4%

What is your share worth?

Current worth
$3.08
Expected worth in 1 year
$3.31
How sure are you?
20.7%

+ What do you gain per year?

Total Gains per Share
$0.23
Return On Investment
1.5%

For what price can you sell your share?

Current Price per Share
$15.24
Expected price per share
$12.85 - $17.25
How sure are you?
50%

1. Valuation of Verona Pharma PLC ADR (5 min.)




Live pricePrice per Share (EOD)

$15.24

Intrinsic Value Per Share

$-6.63 - $-7.86

Total Value Per Share

$-3.55 - $-4.78

2. Growth of Verona Pharma PLC ADR (5 min.)




Is Verona Pharma PLC ADR growing?

Current yearPrevious yearGrowGrow %
How rich?$249.2m$176.2m$89.3m33.6%

How much money is Verona Pharma PLC ADR making?

Current yearPrevious yearGrowGrow %
Making money-$13.6m-$17.1m$3.5m26.1%
Net Profit Margin0.0%-570.5%--

How much money comes from the company's main activities?

3. Financial Health of Verona Pharma PLC ADR (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#207 / 1010

Most Revenue
#824 / 1010

Most Profit
#619 / 1010

Most Efficient
#264 / 1010

What can you expect buying and holding a share of Verona Pharma PLC ADR? (5 min.)

Welcome investor! Verona Pharma PLC ADR's management wants to use your money to grow the business. In return you get a share of Verona Pharma PLC ADR.

What can you expect buying and holding a share of Verona Pharma PLC ADR?

First you should know what it really means to hold a share of Verona Pharma PLC ADR. And how you can make/lose money.

Speculation

The Price per Share of Verona Pharma PLC ADR is $15.24. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Verona Pharma PLC ADR.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Verona Pharma PLC ADR, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.08. Based on the TTM, the Book Value Change Per Share is $0.06 per quarter. Based on the YOY, the Book Value Change Per Share is $0.65 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Verona Pharma PLC ADR.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.18-1.2%-0.14-0.9%-0.05-0.3%-0.07-0.4%-0.06-0.4%
Usd Book Value Change Per Share-0.18-1.2%0.060.4%0.654.3%0.120.8%0.110.7%
Usd Dividend Per Share0.000.0%0.000.0%0.010.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.18-1.2%0.060.4%0.654.3%0.120.8%0.110.7%
Usd Price Per Share19.88-19.35-11.38-9.70-9.95-
Price to Earnings Ratio-28.24--36.37--59.93--32.76--11.60-
Price-to-Total Gains Ratio-112.98--171.05--52.04--326.52--314.34-
Price to Book Ratio6.46-5.90-21.29-17.28-16.30-
Price-to-Total Gains Ratio-112.98--171.05--52.04--326.52--314.34-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share15.24
Number of shares65
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.060.12
Usd Total Gains Per Share0.060.12
Gains per Quarter (65 shares)3.788.11
Gains per Year (65 shares)15.1032.45
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1015503222
20302016454
30453519686
4060501129118
5076652161150
6091802193182
70106952225214
801211103257246
901361253289278
1001511403321310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%3.026.00.010.3%3.026.00.010.3%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%4.016.00.020.0%6.022.01.020.7%6.022.01.020.7%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.028.03.4%1.00.028.03.4%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%4.016.00.020.0%6.022.01.020.7%6.022.01.020.7%

Fundamentals of Verona Pharma PLC ADR

About Verona Pharma PLC ADR

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. The company was incorporated in 2005 and is headquartered in London, the United Kingdom.

Fundamental data was last updated by Penke on 2024-04-12 21:45:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Verona Pharma PLC ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Verona Pharma PLC ADR earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Verona Pharma PLC ADR to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Verona Pharma PLC ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-570.5%+570.5%
TTM-5Y-35,130.6%+35,130.6%
5Y-35,130.6%10Y-28,166.8%-6,963.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY-570.5%-288.3%-282.2%
5Y-35,130.6%-449.1%-34,681.5%
10Y-28,166.8%-605.5%-27,561.3%
1.1.2. Return on Assets

Shows how efficient Verona Pharma PLC ADR is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Verona Pharma PLC ADR to the Biotechnology industry mean.
  • -4.6% Return on Assets means that Verona Pharma PLC ADR generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Verona Pharma PLC ADR:

  • The MRQ is -4.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.6%TTM-4.4%-0.2%
TTM-4.4%YOY-9.0%+4.5%
TTM-4.4%5Y-10.0%+5.6%
5Y-10.0%10Y-8.6%-1.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.6%-13.3%+8.7%
TTM-4.4%-12.8%+8.4%
YOY-9.0%-11.7%+2.7%
5Y-10.0%-13.9%+3.9%
10Y-8.6%-15.7%+7.1%
1.1.3. Return on Equity

Shows how efficient Verona Pharma PLC ADR is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Verona Pharma PLC ADR to the Biotechnology industry mean.
  • -5.7% Return on Equity means Verona Pharma PLC ADR generated $-0.06 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Verona Pharma PLC ADR:

  • The MRQ is -5.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.7%TTM-5.1%-0.6%
TTM-5.1%YOY-11.7%+6.6%
TTM-5.1%5Y-13.8%+8.6%
5Y-13.8%10Y-11.6%-2.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.7%-16.9%+11.2%
TTM-5.1%-16.1%+11.0%
YOY-11.7%-15.1%+3.4%
5Y-13.8%-19.3%+5.5%
10Y-11.6%-20.2%+8.6%

1.2. Operating Efficiency of Verona Pharma PLC ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Verona Pharma PLC ADR is operating .

  • Measures how much profit Verona Pharma PLC ADR makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Verona Pharma PLC ADR to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Verona Pharma PLC ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-778.0%+778.0%
TTM-5Y-39,715.3%+39,715.3%
5Y-39,715.3%10Y-37,761.7%-1,953.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY-778.0%-298.2%-479.8%
5Y-39,715.3%-492.1%-39,223.2%
10Y-37,761.7%-632.4%-37,129.3%
1.2.2. Operating Ratio

Measures how efficient Verona Pharma PLC ADR is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Verona Pharma PLC ADR:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY8.030-8.030
TTM-5Y373.316-373.316
5Y373.31610Y364.864+8.452
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY8.0303.890+4.140
5Y373.3165.739+367.577
10Y364.8647.876+356.988

1.3. Liquidity of Verona Pharma PLC ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Verona Pharma PLC ADR is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 33.33 means the company has $33.33 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Verona Pharma PLC ADR:

  • The MRQ is 33.330. The company is very able to pay all its short-term debts. +2
  • The TTM is 25.468. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ33.330TTM25.468+7.862
TTM25.468YOY7.104+18.364
TTM25.4685Y10.953+14.516
5Y10.95310Y9.691+1.262
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ33.3303.890+29.440
TTM25.4684.173+21.295
YOY7.1045.344+1.760
5Y10.9536.126+4.827
10Y9.6916.448+3.243
1.3.2. Quick Ratio

Measures if Verona Pharma PLC ADR is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Verona Pharma PLC ADR to the Biotechnology industry mean.
  • A Quick Ratio of 32.53 means the company can pay off $32.53 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Verona Pharma PLC ADR:

  • The MRQ is 32.527. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 24.807. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ32.527TTM24.807+7.720
TTM24.807YOY6.907+17.900
TTM24.8075Y11.846+12.961
5Y11.84610Y11.265+0.580
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ32.5273.514+29.013
TTM24.8073.998+20.809
YOY6.9075.380+1.527
5Y11.8466.105+5.741
10Y11.2656.404+4.861

1.4. Solvency of Verona Pharma PLC ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Verona Pharma PLC ADR assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Verona Pharma PLC ADR to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.19 means that Verona Pharma PLC ADR assets are financed with 19.1% credit (debt) and the remaining percentage (100% - 19.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Verona Pharma PLC ADR:

  • The MRQ is 0.191. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.134. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.191TTM0.134+0.057
TTM0.134YOY0.196-0.063
TTM0.1345Y0.204-0.070
5Y0.20410Y0.192+0.012
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1910.339-0.148
TTM0.1340.336-0.202
YOY0.1960.271-0.075
5Y0.2040.366-0.162
10Y0.1920.389-0.197
1.4.2. Debt to Equity Ratio

Measures if Verona Pharma PLC ADR is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Verona Pharma PLC ADR to the Biotechnology industry mean.
  • A Debt to Equity ratio of 23.6% means that company has $0.24 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Verona Pharma PLC ADR:

  • The MRQ is 0.236. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.157. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.236TTM0.157+0.079
TTM0.157YOY0.255-0.098
TTM0.1575Y0.306-0.149
5Y0.30610Y0.277+0.029
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2360.388-0.152
TTM0.1570.402-0.245
YOY0.2550.335-0.080
5Y0.3060.426-0.120
10Y0.2770.461-0.184

2. Market Valuation of Verona Pharma PLC ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Verona Pharma PLC ADR generates.

  • Above 15 is considered overpriced but always compare Verona Pharma PLC ADR to the Biotechnology industry mean.
  • A PE ratio of -28.24 means the investor is paying $-28.24 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Verona Pharma PLC ADR:

  • The EOD is -21.645. Based on the earnings, the company is expensive. -2
  • The MRQ is -28.235. Based on the earnings, the company is expensive. -2
  • The TTM is -36.366. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-21.645MRQ-28.235+6.590
MRQ-28.235TTM-36.366+8.131
TTM-36.366YOY-59.929+23.563
TTM-36.3665Y-32.759-3.607
5Y-32.75910Y-11.597-21.162
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-21.645-2.264-19.381
MRQ-28.235-2.629-25.606
TTM-36.366-2.680-33.686
YOY-59.929-4.145-55.784
5Y-32.759-6.257-26.502
10Y-11.597-6.254-5.343
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Verona Pharma PLC ADR:

  • The EOD is -29.609. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -38.624. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -38.737. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-29.609MRQ-38.624+9.015
MRQ-38.624TTM-38.737+0.113
TTM-38.737YOY-62.167+23.430
TTM-38.7375Y-39.450+0.713
5Y-39.45010Y-53.939+14.490
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-29.609-2.973-26.636
MRQ-38.624-3.333-35.291
TTM-38.737-3.553-35.184
YOY-62.167-5.605-56.562
5Y-39.450-8.376-31.074
10Y-53.939-8.865-45.074
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Verona Pharma PLC ADR is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 6.46 means the investor is paying $6.46 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Verona Pharma PLC ADR:

  • The EOD is 4.951. Based on the equity, the company is fair priced.
  • The MRQ is 6.458. Based on the equity, the company is overpriced. -1
  • The TTM is 5.903. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.951MRQ6.458-1.507
MRQ6.458TTM5.903+0.555
TTM5.903YOY21.288-15.385
TTM5.9035Y17.281-11.378
5Y17.28110Y16.304+0.978
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.9511.896+3.055
MRQ6.4582.115+4.343
TTM5.9032.093+3.810
YOY21.2882.884+18.404
5Y17.2813.542+13.739
10Y16.3043.916+12.388
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Verona Pharma PLC ADR.

3.1. Institutions holding Verona Pharma PLC ADR

Institutions are holding 85.598% of the shares of Verona Pharma PLC ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31RA Capital Management, LLC7.80151.9618631799000
2023-12-31NEA Management Company, LLC6.30817.3995510856300
2023-12-31FMR Inc6.05350.00754902377-2055581-29.5429
2023-12-31Vivo Capital, LLC5.24796.9177424991800
2023-12-31Perceptive Advisors LLC4.77411.71563866214-140983-3.5182
2023-12-31Wellington Management Company LLP4.67250.0143783994-683577-15.3009
2023-12-31Orbimed Advisors, LLC4.66481.4999377777800
2023-12-31Deep Track Capital, LP3.93592.1162318741500
2023-12-31Federated Hermes Inc3.0790.1231249353000
2023-12-31The Carlyle Group Inc3.03462.3473245750000
2023-09-30Octagon Capital Advisors LP2.92535.93252369000-99000-4.0113
2023-12-31HHG PLC2.22680.0214180336116653910.1745
2023-12-31Maverick Capital Ltd2.04550.6613165649216564920
2023-12-31Jennison Associates LLC1.95770.023515853851428199.9003
2023-12-31Eventide Asset Management, LLC1.70130.4471137778152778162.0919
2023-12-31First Turn Management LLC1.48953.444120629112062910
2023-12-31Aisling Capital Management LP1.37736.6142111535200
2023-12-31Hood River Capital Management LLC1.16890.51759466029466020
2023-12-31Bellevue Group AG1.03720.2554839996-16362-1.9106
2023-12-31Avidity Partners Management LP0.96430.5658780900-49400-5.9497
Total 66.465742.585353826439+1601621+3.0%

3.2. Funds holding Verona Pharma PLC ADR

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Eventide Healthcare & Life Sciences I1.70131.6432137778152778162.0919
2023-12-31Federated Hermes Kaufmann R1.64810.5441133472100
2023-12-31Federated Hermes Kaufmann Growth1.64810.5441133472100
2023-12-31Vanguard Health Care Inv1.43240.0497116003200
2023-12-31Federated Hermes Kaufmann Small Cap Grow1.38870.5316112464300
2023-12-31Federated Hermes Kaufmann Small Cap A1.38870.5316112464300
2024-02-29Fidelity Select Biotechnology1.32260.37521071101-268400-20.0373
2023-11-30Bellevue Healthcare Ord0.95981.19497772977772970
2024-03-31Jennison Health Sciences Equity0.86340.609869924000
2024-02-29PGIM Jennison Health Sciences Z0.86340.670469924000
2024-01-31Fidelity Small Cap Growth0.81770.212662186-799-0.1205
2024-01-31FIAM Small Cap Core CIT Cl B0.66540.260953890010530024.2851
2023-12-31Janus Henderson US Small Cap Growth0.61550.325149842600
2023-12-31Janus Henderson Venture D0.61550.322949842600
2023-12-31American Century Small Cap Growth Inv0.60470.303748967123219890.1834
2023-12-31American Century U.S. Small Cap Growth0.60470.303848967123219890.1834
2024-02-29Wellington Global Hlthcr Eq USD G Ac0.5580.2961451907-13190-2.836
2023-12-31FIAM Small Cap Core Composite0.53540.2208433600-11600-2.6056
2023-12-31Hood River Small-Cap Growth Instl0.48650.41863939823939820
2024-03-28iShares Biotechnology ETF0.42580.072734484100
Total 19.14579.431215505029+1974767+12.7%

3.3. Insider Transactions

Insiders are holding 4.276% of the shares of Verona Pharma PLC ADR.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-20Martin EdwardsBUY337361.84
2023-11-06David R EbsworthBUY1600001.98
2023-11-03Kathleen A RickardSELL587521.92
2023-08-07Claire PollSELL15122.47
2023-08-07David ZaccardelliSELL86162.47
2023-08-07Kathleen A RickardSELL16002.47
2023-08-04David ZaccardelliSELL1500002.5
2023-08-03Claire PollSELL206082.54
2023-08-03Kathleen A RickardSELL506002.55
2023-08-03Mark W HahnSELL1172722.54
2023-08-02David ZaccardelliSELL737042.59
2023-08-01Claire PollSELL186082.68
2023-08-01Kathleen A RickardSELL197362.68
2023-08-01Mark W HahnSELL1059442.68
2023-05-15Orbimed Advisors LlcSELL35971320.08
2023-05-11Orbimed Advisors LlcSELL8000022.26
2023-05-03Kathleen A RickardSELL287522.65
2023-05-01Claire PollSELL803762.58
2023-05-01David ZaccardelliSELL4555362.58
2023-05-01Kathleen A RickardSELL774242.58

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Verona Pharma PLC ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1760.058-403%0.649-127%0.124-242%0.106-266%
Book Value Per Share--3.0783.280-6%0.897+243%1.033+198%0.935+229%
Current Ratio--33.33025.468+31%7.104+369%10.953+204%9.691+244%
Debt To Asset Ratio--0.1910.134+43%0.196-3%0.204-6%0.192-1%
Debt To Equity Ratio--0.2360.157+51%0.255-7%0.306-23%0.277-15%
Dividend Per Share----0%0.006-100%0.001-100%0.001-100%
Eps---0.176-0.144-18%-0.053-70%-0.068-61%-0.061-65%
Free Cash Flow Per Share---0.129-0.155+21%-0.045-65%-0.067-48%-0.062-52%
Free Cash Flow To Equity Per Share--0.1690.132+28%0.014+1089%0.023+620%0.024+597%
Gross Profit Margin--1.0001.0000%1.027-3%1.030-3%1.021-2%
Intrinsic Value_10Y_max---7.860--------
Intrinsic Value_10Y_min---6.628--------
Intrinsic Value_1Y_max---0.359--------
Intrinsic Value_1Y_min---0.353--------
Intrinsic Value_3Y_max---1.406--------
Intrinsic Value_3Y_min---1.336--------
Intrinsic Value_5Y_max---2.846--------
Intrinsic Value_5Y_min---2.614--------
Market Cap1234194696.960-30%1609960011.5201567038542.400+3%3653139304.205-56%2399647019.301-33%2075853611.337-22%
Net Profit Margin----0%-5.7050%-351.3060%-281.6680%
Operating Margin----0%-7.7800%-397.1530%-377.6170%
Operating Ratio----0%8.030-100%373.316-100%364.864-100%
Pb Ratio4.951-30%6.4585.903+9%21.288-70%17.281-63%16.304-60%
Pe Ratio-21.645+23%-28.235-36.366+29%-59.929+112%-32.759+16%-11.597-59%
Price Per Share15.240-30%19.88019.350+3%11.383+75%9.700+105%9.955+100%
Price To Free Cash Flow Ratio-29.609+23%-38.624-38.737+0%-62.167+61%-39.450+2%-53.939+40%
Price To Total Gains Ratio-86.610+23%-112.980-171.049+51%-52.043-54%-326.525+189%-314.337+178%
Quick Ratio--32.52724.807+31%6.907+371%11.846+175%11.265+189%
Return On Assets---0.046-0.044-4%-0.090+94%-0.100+117%-0.086+86%
Return On Equity---0.057-0.051-10%-0.117+105%-0.138+141%-0.116+103%
Total Gains Per Share---0.1760.058-403%0.655-127%0.125-241%0.107-264%
Usd Book Value--249283000.000265664500.000-6%176284500.000+41%153563553.056+62%132546063.294+88%
Usd Book Value Change Per Share---0.1760.058-403%0.649-127%0.124-242%0.106-266%
Usd Book Value Per Share--3.0783.280-6%0.897+243%1.033+198%0.935+229%
Usd Dividend Per Share----0%0.006-100%0.001-100%0.001-100%
Usd Eps---0.176-0.144-18%-0.053-70%-0.068-61%-0.061-65%
Usd Free Cash Flow---10420810.000-12560202.500+21%-14972745.430+44%-11415381.345+10%-9742581.794-7%
Usd Free Cash Flow Per Share---0.129-0.155+21%-0.045-65%-0.067-48%-0.062-52%
Usd Free Cash Flow To Equity Per Share--0.1690.132+28%0.014+1089%0.023+620%0.024+597%
Usd Market Cap1234194696.960-30%1609960011.5201567038542.400+3%3653139304.205-56%2399647019.301-33%2075853611.337-22%
Usd Price Per Share15.240-30%19.88019.350+3%11.383+75%9.700+105%9.955+100%
Usd Profit---14254934.000-13622983.500-4%-17175250.000+20%-14078111.013-1%-11599477.251-19%
Usd Revenue----0%114500.000-100%4023135.100-100%2838154.655-100%
Usd Total Gains Per Share---0.1760.058-403%0.655-127%0.125-241%0.107-264%
 EOD+3 -5MRQTTM+11 -18YOY+16 -185Y+16 -1810Y+16 -18

4.2. Fundamental Score

Let's check the fundamental score of Verona Pharma PLC ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-21.645
Price to Book Ratio (EOD)Between0-14.951
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than132.527
Current Ratio (MRQ)Greater than133.330
Debt to Asset Ratio (MRQ)Less than10.191
Debt to Equity Ratio (MRQ)Less than10.236
Return on Equity (MRQ)Greater than0.15-0.057
Return on Assets (MRQ)Greater than0.05-0.046
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Verona Pharma PLC ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.730
Ma 20Greater thanMa 5016.142
Ma 50Greater thanMa 10016.424
Ma 100Greater thanMa 20016.850
OpenGreater thanClose15.860
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Long-term Assets Other  15,073-6115,012-115,011-115,010-15,0100
Tax Provision  28145173137310-26644-97-53



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets308,124
Total Liabilities58,841
Total Stockholder Equity249,283
 As reported
Total Liabilities 58,841
Total Stockholder Equity+ 249,283
Total Assets = 308,124

Assets

Total Assets308,124
Total Current Assets289,708
Long-term Assets18,416
Total Current Assets
Cash And Cash Equivalents 271,772
Net Receivables 10,954
Inventory 0
Other Current Assets 6,982
Total Current Assets  (as reported)289,708
Total Current Assets  (calculated)289,708
+/-0
Long-term Assets
Property Plant Equipment 2,871
Goodwill 545
Long Term Investments 15,000
Long-term Assets Other 0
Long-term Assets  (as reported)18,416
Long-term Assets  (calculated)18,416
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities8,692
Long-term Liabilities50,149
Total Stockholder Equity249,283
Total Current Liabilities
Short-term Debt 1,180
Accounts payable 3,492
Other Current Liabilities 4,020
Total Current Liabilities  (as reported)8,692
Total Current Liabilities  (calculated)8,692
+/- 0
Long-term Liabilities
Long term Debt 48,374
Capital Lease Obligations Min Short Term Debt1,775
Long-term Liabilities  (as reported)50,149
Long-term Liabilities  (calculated)50,149
+/-0
Total Stockholder Equity
Common Stock42,771
Retained Earnings -388,433
Accumulated Other Comprehensive Income -4,601
Other Stockholders Equity 599,546
Total Stockholder Equity (as reported)249,283
Total Stockholder Equity (calculated)249,283
+/-0
Other
Capital Stock42,771
Cash and Short Term Investments 271,772
Common Stock Shares Outstanding 80,267
Current Deferred Revenue0
Liabilities and Stockholders Equity 308,124
Net Debt -220,443
Net Invested Capital 297,657
Net Working Capital 281,016
Property Plant and Equipment Gross 2,871
Short Long Term Debt Total 51,329



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312015-06-302014-12-312014-06-302013-12-312013-06-302012-12-312012-06-302011-12-312011-06-302010-12-312010-06-302009-12-312009-06-302008-12-312008-06-302007-12-312007-06-302006-12-312006-06-302005-12-312005-06-30
> Total Assets 
1,797
1,705
1,898
7,766
7,049
6,039
9,587
5,972
5,415
7,711
6,862
5,644
4,701
6,532
6,493
4,529
4,259
4,217
24,294
20,435
15,327
10,962
7,250
0
56,931
0
133,004
127,136
120,956
116,270
105,441
99,892
94,230
85,041
76,911
67,054
45,135
44,362
64,345
245,827
204,206
190,150
218,502
201,560
186,587
169,315
154,856
274,872
259,468
323,146
303,929
292,470
308,124
308,124292,470303,929323,146259,468274,872154,856169,315186,587201,560218,502190,150204,206245,82764,34544,36245,13567,05476,91185,04194,23099,892105,441116,270120,956127,136133,004056,93107,25010,96215,32720,43524,2944,2174,2594,5296,4936,5324,7015,6446,8627,7115,4155,9729,5876,0397,0497,7661,8981,7051,797
   > Total Current Assets 
1,797
1,705
1,898
4,733
3,936
2,961
6,486
3,695
2,861
5,192
4,493
3,198
2,173
4,063
4,001
1,889
1,731
1,407
21,160
17,522
12,539
8,256
4,737
0
54,054
0
129,862
123,843
117,678
112,705
102,102
96,517
90,936
81,282
73,330
62,355
40,923
38,839
31,106
212,474
202,504
188,601
216,283
184,492
170,063
152,955
138,632
258,454
242,996
306,891
287,831
276,527
289,708
289,708276,527287,831306,891242,996258,454138,632152,955170,063184,492216,283188,601202,504212,47431,10638,83940,92362,35573,33081,28290,93696,517102,102112,705117,678123,843129,862054,05404,7378,25612,53917,52221,1601,4071,7311,8894,0014,0632,1733,1984,4935,1922,8613,6956,4862,9613,9364,7331,8981,7051,797
       Cash And Cash Equivalents 
1,793
1,690
1,595
2,083
3,725
2,483
6,301
3,595
2,752
4,576
4,376
3,091
1,848
3,922
3,701
1,553
1,415
996
20,608
15,518
9,583
5,221
1,609
0
49,087
0
81,462
42,057
42,492
40,662
47,817
35,909
25,104
24,424
28,430
41,575
22,934
24,813
22,256
201,968
187,986
169,598
146,035
166,547
148,380
132,764
111,510
231,701
227,827
291,415
270,727
257,366
271,772
271,772257,366270,727291,415227,827231,701111,510132,764148,380166,547146,035169,598187,986201,96822,25624,81322,93441,57528,43024,42425,10435,90947,81740,66242,49242,05781,462049,08701,6095,2219,58315,51820,6089961,4151,5533,7013,9221,8483,0914,3764,5762,7523,5956,3012,4833,7252,0831,5951,6901,793
       Short-term Investments 
0
0
0
2,547
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41,576
72,429
65,974
61,113
42,205
53,847
56,998
46,053
30,530
8,902
7,823
866
7,823
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000007,8238667,8238,90230,53046,05356,99853,84742,20561,11365,97472,42941,57600000000000000000000002,547000
       Net Receivables 
4
0
0
0
211
0
185
0
109
0
117
0
325
0
300
0
0
0
0
0
0
0
0
0
1,138
0
2,810
3,069
7,673
10,930
12,080
6,761
7,106
66,034
65,119
39,544
8,857
8,667
8,850
10,506
8,260
10,649
58,111
10,606
15,583
16,420
20,185
20,321
9,282
11,842
10,150
9,510
10,954
10,9549,51010,15011,8429,28220,32120,18516,42015,58310,60658,11110,6498,26010,5068,8508,6678,85739,54465,11966,0347,1066,76112,08010,9307,6733,0692,81001,138000000000300032501170109018502110004
       Inventory 
-4
0
0
0
-211
0
-185
0
-109
0
-117
0
-325
0
-300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-8,850
-10,506
4,538
6,870
9,817
6,672
4,037
1,246
4,731
3,355
2,499
1,561
894
3,332
0
03,3328941,5612,4993,3554,7311,2464,0376,6729,8176,8704,538-10,506-8,85000000000000000000000000-3000-3250-1170-1090-1850-211000-4
       Other Current Assets 
4
2
303
20
211
196
185
28
109
325
117
28
325
141
300
113
208
107
324
923
1,880
1,852
1,825
0
2,665
0
4,014
6,288
1,538
0
630,640,687,973
1,000,000,000,000,000
1,728
10,805
14,370
11,878
13,329
13,160
8,850
10,506
1,720
1,484
2,320
667
2,063
2,525
2,206
3,077
3,388
2,073
6,060
6,319
6,982
6,9826,3196,0602,0733,3883,0772,2062,5252,0636672,3201,4841,72010,5068,85013,16013,32911,87814,37010,8051,7281,000,000,000,000,000630,640,687,97301,5386,2884,01402,66501,8251,8521,88092332410720811330014132528117325109281851962112030324
   > Long-term Assets 
0
1,690
0
3,033
3,113
3,078
3,101
2,277
2,555
2,519
2,369
2,446
2,528
2,469
2,493
2,640
2,528
2,810
3,134
2,913
2,787
2,707
2,512
0
2,877
0
3,142
3,292
3,279
3,565
3,339
3,375
3,294
3,759
3,581
4,699
4,212
5,523
33,239
33,353
1,702
1,549
2,219
17,068
16,524
16,360
16,224
16,418
16,472
16,255
16,098
15,943
18,416
18,41615,94316,09816,25516,47216,41816,22416,36016,52417,0682,2191,5491,70233,35333,2395,5234,2124,6993,5813,7593,2943,3753,3393,5653,2793,2923,14202,87702,5122,7072,7872,9133,1342,8102,5282,6402,4932,4692,5282,4462,3692,5192,5552,2773,1013,0783,1133,03301,6900
       Property Plant Equipment 
0
0
0
33
28
32
36
21
18
29
26
23
16
9
19
64
51
46
40
34
28
20
13
0
17
0
17
17
22
21
17
14
27
352
267
1,403
1,014
1,549
1,395
1,301
1,157
1,004
1,674
1,523
979
815
679
874
927
710
553
398
2,871
2,8713985537109278746798159791,5231,6741,0041,1571,3011,3951,5491,0141,403267352271417212217170170132028344046516419916232629182136322833000
       Goodwill 
0
0
0
2,878
2,950
2,913
2,924
2,151
2,417
2,375
2,211
2,267
2,361
2,281
2,307
2,374
2,233
2,423
2,502
2,287
2,310
2,176
1,961
0
544
0
574
591
596
618
577
575
560
575
559
542
441
546
543
545
545
545
545
545
545
545
545
544
545
545
545
545
545
545545545545545544545545545545545545545545543546441542559575560575577618596591574054401,9612,1762,3102,2872,5022,4232,2332,3742,3072,2812,3612,2672,2112,3752,4172,1512,9242,9132,9502,878000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,000
15,000
15,000
15,000
15,000
15,000
15,000
15,000
15,000
15,000
15,00015,00015,00015,00015,00015,00015,00015,00015,00015,0000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
121
135
133
141
105
120
115
132
156
151
179
166
202
244
342
592
592
450
510
538
0
2,315
0
2,552
2,684
2,661
2,926
2,746
2,786
2,708
2,832
2,755
2,755
2,757
3,429
31,302
31,507
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000031,50731,3023,4292,7572,7552,7552,8322,7082,7862,7462,9262,6612,6842,55202,3150538510450592592342244202166179151156132115120105141133135121000
       Other Assets 
0
-1,690
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,860
0
3,121
0
3,260
4,982
173,436,534,724
1,000,000,000,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000001,000,000,000,000,000173,436,534,7244,9823,26003,12102,8600000000000000000000000-1,6900
> Total Liabilities 
13
21
248
129
141
311
587
123
94
464
98
318
460
242
157
322
265
807
690
816
898
2,686
1,688
0
14,404
0
11,776
12,967
13,005
24,261
18,093
14,944
14,373
9,242
13,772
17,538
11,270
12,418
40,720
48,112
19,352
17,736
64,105
33,358
38,582
43,008
43,976
37,387
29,002
46,397
30,836
28,937
58,841
58,84128,93730,83646,39729,00237,38743,97643,00838,58233,35864,10517,73619,35248,11240,72012,41811,27017,53813,7729,24214,37314,94418,09324,26113,00512,96711,776014,40401,6882,68689881669080726532215724246031898464941235873111411292482113
   > Total Current Liabilities 
13
21
248
129
141
311
587
123
94
464
98
318
460
242
157
322
265
807
690
816
898
2,686
1,688
0
13,414
0
10,689
11,826
11,617
22,818
16,706
13,537
12,975
7,791
12,328
15,316
9,616
9,927
10,413
16,859
14,203
12,698
58,364
27,740
33,422
37,903
38,863
32,128
19,029
26,523
10,949
9,012
8,692
8,6929,01210,94926,52319,02932,12838,86337,90333,42227,74058,36412,69814,20316,85910,4139,9279,61615,31612,3287,79112,97513,53716,70622,81811,61711,82610,689013,41401,6882,68689881669080726532215724246031898464941235873111411292482113
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
76
0
0
0
0
314
207
541
460
771
785
808
798
757
749
690
648
583
464
569
675
650
545
376
1,180
1,1803765456506755694645836486907497577988087857714605412073140000760000000000000000000000000000
       Accounts payable 
13
0
248
67
141
194
587
72
94
189
98
219
460
138
157
219
265
544
690
571
898
1,899
1,688
0
887
0
6,906
6,366
1,641
8,081
7,229
7,468
3,602
6,326
11,147
14,265
1,455
8,188
8,753
14,194
178
541
34
9
10,044
8,064
9,364
8,002
2,910
7,237
2,493
823
3,492
3,4928232,4937,2372,9108,0029,3648,06410,04493454117814,1948,7538,1881,45514,26511,1476,3263,6027,4687,2298,0811,6416,3666,906088701,6881,89989857169054426521915713846021998189947258719414167248013
       Other Current Liabilities 
0
21
0
63
0
117
0
51
0
275
0
99
0
104
0
103
0
263
0
245
0
786
0
0
12,527
0
3,783
5,460
9,748
14,737
9,477
6,069
9,372
1,150
975
510
7,701
969
875
1,857
2,364
2,886
17,530
187
327
29,256
19,671
23,557
15,444
18,636
444
416
4,020
4,02041644418,63615,44423,55719,67129,25632718717,5302,8862,3641,8578759697,7015109751,1509,3726,0699,47714,7379,7485,4603,783012,527007860245026301030104099027505101170630210
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
990
0
1,087
1,141
1,388
1,444
1,387
1,407
1,398
1,452
1,443
2,222
1,654
2,491
30,307
31,253
5,149
5,038
5,741
5,618
5,160
5,105
5,113
5,259
9,973
19,874
19,887
19,925
50,149
50,14919,92519,88719,8749,9735,2595,1135,1055,1605,6185,7415,0385,14931,25330,3072,4911,6542,2221,4431,4521,3981,4071,3871,4441,3881,1411,0870990000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
640
491
809
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000080949164000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
989
0
1,086
1,142
1,390
1,447
1,394
1,409
2,289
1,113
1,139
1,168
1,163
1,205
29,648
30,586
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000030,58629,6481,2051,1631,1681,1391,1132,2891,4091,3941,4471,3901,1421,0860989000000000000000000000000
> Total Stockholder Equity
1,784
1,685
1,650
7,637
6,909
5,727
9,000
5,849
5,322
7,247
6,765
5,326
4,242
6,290
6,336
4,207
3,994
3,410
23,603
19,618
14,428
8,277
5,562
0
42,527
34,468
121,228
114,169
107,952
92,009
87,348
84,948
79,857
75,799
63,140
49,516
33,865
31,944
23,624
197,715
184,854
172,414
154,397
168,202
148,005
126,307
110,880
237,485
230,466
276,749
273,093
263,533
249,283
249,283263,533273,093276,749230,466237,485110,880126,307148,005168,202154,397172,414184,854197,71523,62431,94433,86549,51663,14075,79979,85784,94887,34892,009107,952114,169121,22834,46842,52705,5628,27714,42819,61823,6033,4103,9944,2076,3366,2904,2425,3266,7657,2475,3225,8499,0005,7276,9097,6371,6501,6851,784
   Common Stock
90
86
92
282
289
292
412
315
354
375
360
370
386
444
482
496
511
614
1,720
1,572
1,588
1,496
1,348
0
3,168
0
6,823
7,034
7,096
7,359
6,865
6,861
6,682
6,868
6,674
6,473
5,266
6,570
6,553
30,054
31,794
31,794
31,824
31,855
31,855
32,182
32,182
39,119
40,526
41,753
41,753
41,753
42,771
42,77141,75341,75341,75340,52639,11932,18232,18231,85531,85531,82431,79431,79430,0546,5536,5705,2666,4736,6746,8686,6826,8616,8657,3597,0967,0346,82303,16801,3481,4961,5881,5721,720614511496482444386370360375354315412292289282928690
   Retained Earnings 
-34
45
-52
-1,140
-2,089
-3,568
-4,852
-4,644
-6,318
-7,548
-8,201
-10,066
-12,042
-12,748
-14,567
-17,165
-17,692
-21,651
-24,653
-24,489
-30,501
-34,217
-32,845
0
-35,445
0
-44,047
-57,584
-66,562
-90,403
-83,478
-86,228
-87,703
-97,243
-105,836
-115,095
-100,627
-136,267
-144,710
-180,041
-207,050
-228,370
-251,265
-240,287
-263,716
-288,739
-306,653
-322,442
-333,097
-350,110
-359,143
-374,053
-388,433
-388,433-374,053-359,143-350,110-333,097-322,442-306,653-288,739-263,716-240,287-251,265-228,370-207,050-180,041-144,710-136,267-100,627-115,095-105,836-97,243-87,703-86,228-83,478-90,403-66,562-57,584-44,0470-35,4450-32,845-34,217-30,501-24,489-24,653-21,651-17,692-17,165-14,567-12,748-12,042-10,066-8,201-7,548-6,318-4,644-4,852-3,568-2,089-1,140-5245-34
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
193,478
118,862
118,862
118,862
118,862
118,862
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000118,862118,862118,862118,862118,862193,47800000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
1,729
1,554
1,609
8,497
8,708
9,017
13,440
10,204
11,286
14,471
14,605
15,085
15,898
18,672
20,421
20,977
21,175
24,560
46,536
42,660
43,341
41,130
37,059
0
74,807
0
158,452
164,719
167,418
175,052
163,962
164,315
160,878
166,173
162,302
158,137
169,982
161,642
161,781
330,068
364,711
373,591
378,439
381,235
384,467
387,465
389,952
525,409
527,638
589,707
595,084
600,434
599,546
599,546600,434595,084589,707527,638525,409389,952387,465384,467381,235378,439373,591364,711330,068161,781161,642169,982158,137162,302166,173160,878164,315163,962175,052167,418164,719158,452074,807037,05941,13043,34142,66046,53624,56021,17520,97720,42118,67215,89815,08514,60514,47111,28610,20413,4409,0178,7088,4971,6091,5541,729



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue458
Cost of Revenue-680
Gross Profit-680-222
 
Operating Income (+$)
Gross Profit-680
Operating Expense-67,151
Operating Income-67,831-67,831
 
Operating Expense (+$)
Research Development17,283
Selling General Administrative43,704
Selling And Marketing Expenses-
Operating Expense67,15160,987
 
Net Interest Income (+$)
Interest Income11,331
Interest Expense-2,065
Other Finance Cost-401
Net Interest Income9,667
 
Pretax Income (+$)
Operating Income-67,831
Net Interest Income9,667
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-55,212-80,450
EBIT - interestExpense = -69,896
-55,212
-52,515
Interest Expense2,065
Earnings Before Interest and Taxes (EBIT)-67,831-53,147
Earnings Before Interest and Taxes (EBITDA)-67,151
 
After tax Income (+$)
Income Before Tax-55,212
Tax Provision-555
Net Income From Continuing Ops-50,688-55,767
Net Income-54,580
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses67,831
Total Other Income/Expenses Net12,619-9,667
 

Technical Analysis of Verona Pharma PLC ADR
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Verona Pharma PLC ADR. The general trend of Verona Pharma PLC ADR is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Verona Pharma PLC ADR's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Verona Pharma PLC ADR.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 15.60 < 16.53 < 17.25.

The bearish price targets are: 15.28 > 15.11 > 12.85.

Tweet this
Verona Pharma PLC ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Verona Pharma PLC ADR. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Verona Pharma PLC ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Verona Pharma PLC ADR. The current macd is -0.22085002.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Verona Pharma PLC ADR price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Verona Pharma PLC ADR. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Verona Pharma PLC ADR price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Verona Pharma PLC ADR Daily Moving Average Convergence/Divergence (MACD) ChartVerona Pharma PLC ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Verona Pharma PLC ADR. The current adx is 10.50.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Verona Pharma PLC ADR shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Verona Pharma PLC ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Verona Pharma PLC ADR. The current sar is 16.68.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Verona Pharma PLC ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Verona Pharma PLC ADR. The current rsi is 37.73. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Verona Pharma PLC ADR Daily Relative Strength Index (RSI) ChartVerona Pharma PLC ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Verona Pharma PLC ADR. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Verona Pharma PLC ADR price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Verona Pharma PLC ADR Daily Stochastic Oscillator ChartVerona Pharma PLC ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Verona Pharma PLC ADR. The current cci is -161.90075585.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Verona Pharma PLC ADR Daily Commodity Channel Index (CCI) ChartVerona Pharma PLC ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Verona Pharma PLC ADR. The current cmo is -36.7606485.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Verona Pharma PLC ADR Daily Chande Momentum Oscillator (CMO) ChartVerona Pharma PLC ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Verona Pharma PLC ADR. The current willr is -96.63461538.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Verona Pharma PLC ADR Daily Williams %R ChartVerona Pharma PLC ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Verona Pharma PLC ADR.

Verona Pharma PLC ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Verona Pharma PLC ADR. The current atr is 0.66627521.

Verona Pharma PLC ADR Daily Average True Range (ATR) ChartVerona Pharma PLC ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Verona Pharma PLC ADR. The current obv is 58,678,385.

Verona Pharma PLC ADR Daily On-Balance Volume (OBV) ChartVerona Pharma PLC ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Verona Pharma PLC ADR. The current mfi is 29.84.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Verona Pharma PLC ADR Daily Money Flow Index (MFI) ChartVerona Pharma PLC ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Verona Pharma PLC ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-24BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Verona Pharma PLC ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Verona Pharma PLC ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.730
Ma 20Greater thanMa 5016.142
Ma 50Greater thanMa 10016.424
Ma 100Greater thanMa 20016.850
OpenGreater thanClose15.860
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Verona Pharma PLC ADR with someone you think should read this too:
  • Are you bullish or bearish on Verona Pharma PLC ADR? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Verona Pharma PLC ADR? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Verona Pharma PLC ADR

I send you an email if I find something interesting about Verona Pharma PLC ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Verona Pharma PLC ADR.

Receive notifications about Verona Pharma PLC ADR in your mailbox!